Hypoglycemic and hypolipidemic effects of khellin: Experimental study
Seiten
2018
Scholar's Press (Verlag)
978-620-2-30625-6 (ISBN)
Scholar's Press (Verlag)
978-620-2-30625-6 (ISBN)
- Titel nicht im Sortiment
- Artikel merken
The present work tackled the development and evaluation of inclusion complex of khellin (KH) and methyl-beta-cyclodextrin (MbetaCD). In addition, it tested its possible hypoglycemic and hypolipidemic effects. This study points for the first time that the complexation of Khellin with Methyl-betaCyclodextrin could notably improve the dissolution rate and hence the bioavailability of khellin. Moreover, this study demonstrated that this compound has a hypoglycemic and hypolipidemic effect. Thus, it can be a promising natural supportive treatment for type 2 diabetes mellitus (T2DM).
Mona Mahmoud AbouSamraNational Research Center (NRC), El-Bohouth street, Dokki, Giza. Experience in the field of drug formulation using the Nanotechnology. Several publications in the field of pharmaceutical technology concerned with recent advances in drug delivery and nanotechnology.
| Erscheinungsdatum | 23.09.2022 |
|---|---|
| Sprache | englisch |
| Maße | 150 x 220 mm |
| Gewicht | 94 g |
| Themenwelt | Medizin / Pharmazie ► Pharmazie |
| Schlagworte | Cyclodextrin complexation • hypoglycemic effect • Khellin |
| ISBN-10 | 620-2-30625-4 / 6202306254 |
| ISBN-13 | 978-620-2-30625-6 / 9786202306256 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
mikroskopisches Praktikum
Buch | Softcover (2025)
Deutscher Apotheker Verlag
CHF 39,20
Pharmaceuticals, Diagnostics, Medical Devices
Buch | Hardcover (2023)
Wiley-VCH (Verlag)
CHF 138,60
